By this rigorous study design, we have for the first time demonstrated the inverse relationship between IL‐22 expression and disease severity of IPF in the clinical cohort, and established the causal role of IL‐22 in the protection against pulmonary fibrosis by inhibiting the TGFβ pathway. Here, IL22 is linked to pulmonary fibrosis.